cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

Rhea-AI Summary

cbdMD (NYSE American: YCBD) has scheduled a conference call on Wednesday, December 18, 2024, at 4:20 p.m. Eastern Time to discuss their fourth quarter and fiscal year 2024 financial results ending September 30, 2024. The company will provide updates on financial performance and business progress. Participants can join via USA/Canada (844-763-8274) or International (647-484-8814) lines. A replay will be available through January 18, 2026, accessible via USA/Canada (855-669-9658) or International (412-317-0088) numbers using passcode 5369354.

Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, December 18, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.

CONFERENCE CALL DETAILS

Wednesday, December 18, 2024, 4:20 p.m. Eastern Time
USA/Canada:	844-763-8274
International:	647-484-8814
Teleconference Replay dial in:
USA/Canada:	855-669-9658
International:	412-317-0088
Replay Passcode:	5369354
Webcast/Webcast Replay link - available through January 18, 2026:
https://www.gowebcasting.com/13876

 

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free¹ CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. cbdMD also operates ATRx Labs, a line of functional mushroom supplements. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.

¹ THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CEO
Phone: +1 (704) 445-3064 email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/234310

FAQ

When will YCBD release its Q4 and FY2024 earnings results?

cbdMD (YCBD) will release its Q4 and fiscal year 2024 earnings results on Wednesday, December 18, 2024, during a conference call at 4:20 p.m. Eastern Time.

How can investors access YCBD's Q4 2024 earnings call?

Investors can access the call using USA/Canada number 844-763-8274 or International number 647-484-8814. A webcast replay will be available through January 18, 2026.

What period will YCBD's upcoming earnings report cover?

The earnings report will cover the fourth quarter and fiscal year 2024, ending September 30, 2024.

How long will YCBD's Q4 2024 earnings call replay be available?

The earnings call replay will be available through January 18, 2026, accessible via USA/Canada (855-669-9658) or International (412-317-0088) numbers using passcode 5369354.